Boston Scientific Corporation (VIE:BSXC)
77.80
+0.20 (0.26%)
At close: Jan 30, 2026
Boston Scientific Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 414 | 865 | 928 | 1,925 |
Cash & Short-Term Investments | 1,275 | 414 | 865 | 928 | 1,925 |
Cash Growth | 207.97% | -52.14% | -6.79% | -51.79% | 11.02% |
Accounts Receivable | - | 2,558 | 2,228 | 1,970 | 1,778 |
Receivables | - | 2,558 | 2,228 | 1,970 | 1,778 |
Inventory | - | 2,810 | 2,484 | 1,867 | 1,610 |
Restricted Cash | - | 111 | 130 | 149 | 188 |
Other Current Assets | - | 1,027 | 807 | 846 | 816 |
Total Current Assets | - | 6,920 | 6,514 | 5,760 | 6,317 |
Property, Plant & Equipment | - | 3,743 | 3,298 | 2,832 | 2,687 |
Long-Term Investments | - | 556 | 413 | 407 | 411 |
Goodwill | - | 17,089 | 14,387 | 12,920 | 11,988 |
Other Intangible Assets | - | 6,684 | 6,003 | 5,969 | 6,235 |
Long-Term Deferred Tax Assets | - | 3,655 | 3,841 | 3,942 | 4,142 |
Other Long-Term Assets | - | 748 | 680 | 639 | 449 |
Total Assets | - | 39,395 | 35,136 | 32,469 | 32,229 |
Accounts Payable | - | 960 | 942 | 862 | 794 |
Accrued Expenses | - | 2,533 | 2,136 | 1,855 | 1,883 |
Current Portion of Long-Term Debt | - | 1,778 | 531 | 20 | 261 |
Current Portion of Leases | - | 81 | 76 | 61 | 71 |
Current Income Taxes Payable | - | 268 | 220 | 232 | 209 |
Current Unearned Revenue | - | 306 | 266 | 220 | 208 |
Other Current Liabilities | - | 473 | 762 | 553 | 848 |
Total Current Liabilities | - | 6,399 | 4,933 | 3,803 | 4,274 |
Long-Term Debt | - | 8,842 | 8,566 | 8,910 | 8,798 |
Long-Term Leases | - | 527 | 395 | 352 | 395 |
Long-Term Unearned Revenue | - | 329 | 311 | 289 | 276 |
Long-Term Deferred Tax Liabilities | - | 155 | 134 | 144 | 310 |
Other Long-Term Liabilities | - | 1,140 | 1,267 | 1,398 | 1,554 |
Total Liabilities | - | 17,392 | 15,606 | 14,896 | 15,607 |
Common Stock | - | 17 | 17 | 17 | 17 |
Additional Paid-In Capital | - | 21,056 | 20,647 | 20,289 | 19,986 |
Retained Earnings | - | 2,673 | 819 | -750 | -1,392 |
Treasury Stock | - | -2,251 | -2,251 | -2,251 | -2,251 |
Comprehensive Income & Other | - | 275 | 50 | 268 | 262 |
Total Common Equity | 23,394 | 21,770 | 19,282 | 17,573 | 16,622 |
Minority Interest | - | 233 | 248 | - | - |
Shareholders' Equity | 23,630 | 22,003 | 19,530 | 17,573 | 16,622 |
Total Liabilities & Equity | - | 39,395 | 35,136 | 32,469 | 32,229 |
Total Debt | 12,045 | 11,228 | 9,568 | 9,343 | 9,525 |
Net Cash (Debt) | -10,770 | -10,814 | -8,703 | -8,415 | -7,600 |
Net Cash Per Share | -7.21 | -7.28 | -5.95 | -5.84 | -5.30 |
Filing Date Shares Outstanding | 1,482 | 1,476 | 1,467 | 1,435 | 1,427 |
Total Common Shares Outstanding | 1,482 | 1,475 | 1,466 | 1,433 | 1,426 |
Working Capital | - | 521 | 1,581 | 1,957 | 2,043 |
Book Value Per Share | 15.78 | 14.76 | 13.16 | 12.26 | 11.66 |
Tangible Book Value | -1,982 | -2,003 | -1,108 | -1,316 | -1,601 |
Tangible Book Value Per Share | -1.34 | -1.36 | -0.76 | -0.92 | -1.12 |
Land | - | 144 | 140 | 137 | 109 |
Buildings | - | 2,019 | 1,843 | 1,695 | 1,523 |
Machinery | - | 3,629 | 3,503 | 3,298 | 3,288 |
Construction In Progress | - | 1,035 | 857 | 598 | 605 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.